Correlation Between Nanobac Pharmaceuticals and Nuveen Core

Can any of the company-specific risk be diversified away by investing in both Nanobac Pharmaceuticals and Nuveen Core at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanobac Pharmaceuticals and Nuveen Core into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nanobac Pharmaceuticals Incorporated and Nuveen Core Plus, you can compare the effects of market volatilities on Nanobac Pharmaceuticals and Nuveen Core and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanobac Pharmaceuticals with a short position of Nuveen Core. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanobac Pharmaceuticals and Nuveen Core.

Diversification Opportunities for Nanobac Pharmaceuticals and Nuveen Core

0.0

Correlation Coefficient

Nanobac Pharmaceuticals  Nuveen Core

Pay attention - limited upside

The 3 months correlation between Nanobac and Nuveen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Nanobac Pharmaceuticals Incorp and Nuveen Core Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuveen Core Plus and Nanobac Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanobac Pharmaceuticals Incorporated are associated (or correlated) with Nuveen Core. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuveen Core Plus has no effect on the direction of Nanobac Pharmaceuticals i.e., Nanobac Pharmaceuticals and Nuveen Core go up and down completely randomly.

Pair Corralation between Nanobac Pharmaceuticals and Nuveen Core

If you would invest  1,117  in Nuveen Core Plus on September 1, 2024 and sell it today you would earn a total of  19.00  from holding Nuveen Core Plus or generate 1.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Nanobac Pharmaceuticals Incorp  vs.  Nuveen Core Plus

Nanobac Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nanobac Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Nanobac Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Nuveen Core Plus

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Nuveen Core Plus are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable fundamental indicators, Nuveen Core is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Nanobac Pharmaceuticals and Nuveen Core

The main advantage of trading using opposite Nanobac Pharmaceuticals and Nuveen Core positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanobac Pharmaceuticals position performs unexpectedly, Nuveen Core can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuveen Core will offset losses from the drop in Nuveen Core's long position.

The idea behind Nanobac Pharmaceuticals Incorporated and Nuveen Core Plus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.